Democrats will have to limit their drug pricing reforms to Medicare to comply with Senate rules
WASHINGTON — Democrats will likely have to axe two provisions from their drug pricing plan to fit in with Senate rules, both of which would have brought down drug prices for people who get health insurance through their jobs.
Democrats had hoped to cap insulin costs for patients with employer-sponsored health insurance in the massive climate, tax and health bill they’re hoping to advance as soon as this weekend. They also wanted to protect the same pool of people, who get health insurance through their jobs, from bearing the brunt of future drug price hikes.
